Free Trial

Verici Dx (VRCI) Competitors

Verici Dx logo
GBX 0.55 -0.11 (-16.03%)
As of 07/25/2025 11:43 AM Eastern

VRCI vs. GDR, PRM, GENI, DMTR, LLAI, LLA, IDHC, DXRX, AGL, and YGEN

Should you be buying Verici Dx stock or one of its competitors? The main competitors of Verici Dx include genedrive (GDR), Proteome Sciences (PRM), GENinCode (GENI), Deepmatter Group (DMTR), LungLife AI (LLAI), LLA.L,0P0001T9GN,0 (LLA), Integrated Diagnostics (IDHC), Diaceutics (DXRX), ANGLE (AGL), and Yourgene Health (YGEN). These companies are all part of the "diagnostics & research" industry.

Verici Dx vs. Its Competitors

genedrive (LON:GDR) and Verici Dx (LON:VRCI) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, analyst recommendations, media sentiment, institutional ownership, earnings and risk.

Verici Dx has higher revenue and earnings than genedrive. genedrive is trading at a lower price-to-earnings ratio than Verici Dx, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
genedrive£1.50M5.10-£21.22M-£3.57-0.38
Verici Dx£5.91M0.28-£6.56M-£1.73-0.32

In the previous week, genedrive's average media sentiment score of 0.00 equaled Verici Dx'saverage media sentiment score.

Company Overall Sentiment
genedrive Neutral
Verici Dx Neutral

0.3% of genedrive shares are owned by institutional investors. Comparatively, 51.9% of Verici Dx shares are owned by institutional investors. 14.8% of genedrive shares are owned by insiders. Comparatively, 17.1% of Verici Dx shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Verici Dx has a net margin of -110.99% compared to genedrive's net margin of -1,412.18%. Verici Dx's return on equity of -71.67% beat genedrive's return on equity.

Company Net Margins Return on Equity Return on Assets
genedrive-1,412.18% -191.22% -74.09%
Verici Dx -110.99%-71.67%-26.14%

genedrive has a beta of -0.04, meaning that its stock price is 104% less volatile than the S&P 500. Comparatively, Verici Dx has a beta of 1.59, meaning that its stock price is 59% more volatile than the S&P 500.

Summary

Verici Dx beats genedrive on 10 of the 11 factors compared between the two stocks.

Get Verici Dx News Delivered to You Automatically

Sign up to receive the latest news and ratings for VRCI and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VRCI vs. The Competition

MetricVerici DxDiagnostics & Research IndustryMedical SectorLON Exchange
Market Cap£1.67M£847.41M£5.74B£3.02B
Dividend YieldN/A5.44%4.71%5.02%
P/E Ratio-0.322.2428.41160.65
Price / Sales0.28489.21443.64278,114.26
Price / Cash1.3111.4236.1827.97
Price / Book0.122.718.654.70
Net Income-£6.56M£334.07B£3.25B£5.90B
7 Day Performance-29.31%1.45%4.31%0.41%
1 Month Performance-53.19%0.15%11.60%7.20%
1 Year Performance-92.41%-4.52%35.38%70.37%

Verici Dx Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VRCI
Verici Dx
N/AGBX 0.55
-16.0%
N/A-92.1%£1.67M£5.91M-0.3219Gap Down
GDR
genedrive
N/AGBX 1.39
-0.7%
N/A-67.1%£7.89M£1.50M-0.3943
PRM
Proteome Sciences
N/AGBX 2.61
-14.2%
N/A-10.6%£7.70M£10.88B-1.89240Gap Down
GENI
GENinCode
N/AGBX 1.99
+4.5%
N/A-71.3%£3.52M£2.67M-0.582,300Gap Down
DMTR
Deepmatter Group
N/AN/AN/AN/A£1.33M£1.04M-0.11N/AGap Down
LLAI
LungLife AI
N/AGBX 3.50
-17.6%
N/A-75.7%£1.16M£33.87K-0.2815Gap Down
High Trading Volume
LLA
LLA.L,0P0001T9GN,0
N/AN/AN/AN/A£0.00N/A-25.0015Gap Down
High Trading Volume
IDHC
Integrated Diagnostics
N/AGBX 0.32
-3.9%
N/A+28.6%£9.48B£23.29T11.976,692
DXRX
Diaceutics
2.4958 of 5 stars
GBX 127.19
+6.9%
GBX 168.33
+32.3%
+1.5%£107.34M£26.08M-37.72151News Coverage
Analyst Forecast
Gap Up
High Trading Volume
AGL
ANGLE
1.6878 of 5 stars
GBX 6.69
+11.5%
GBX 40
+498.0%
-59.0%£21.56M£2.44M-0.99650Gap Down
YGEN
Yourgene Health
N/AN/AN/AN/A£16.43M£29.67M-51.50253

Related Companies and Tools


This page (LON:VRCI) was last updated on 7/27/2025 by MarketBeat.com Staff
From Our Partners